[
  {
    "ts": null,
    "headline": "Is Bristol-Myers Squibb Company (BMY) The Best Cheap Dividend Stock To Buy Right Now?",
    "summary": "We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best cheap dividend stocks to buy right now. Value investing has remained a favored approach among investors for years, largely popularized […]",
    "url": "https://finnhub.io/api/news?id=1f1adfa96970a4cde325be232b52e1ef6158e4324862e6ee64c6033dd72d9eed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741461617,
      "headline": "Is Bristol-Myers Squibb Company (BMY) The Best Cheap Dividend Stock To Buy Right Now?",
      "id": 133185690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best cheap dividend stocks to buy right now. Value investing has remained a favored approach among investors for years, largely popularized […]",
      "url": "https://finnhub.io/api/news?id=1f1adfa96970a4cde325be232b52e1ef6158e4324862e6ee64c6033dd72d9eed"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis",
    "summary": "PRINCETON, N.J., March 08, 2025--Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared...",
    "url": "https://finnhub.io/api/news?id=5e685790b88f101551343b10c70236e7245444f8017dff03cdf11d413ee5ce97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741442460,
      "headline": "Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis",
      "id": 133185691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., March 08, 2025--Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared...",
      "url": "https://finnhub.io/api/news?id=5e685790b88f101551343b10c70236e7245444f8017dff03cdf11d413ee5ce97"
    }
  },
  {
    "ts": null,
    "headline": "I'm Locking 9-11% FCF Yields On These Dividend Icons",
    "summary": "Bristol Myers Squibb and Alexandria Real Estate are top picks for the income-focused, offering high dividends and growth potential. Click for more on BMY and ARE.",
    "url": "https://finnhub.io/api/news?id=36c0c846c535e0e09a1de09ae463b5dce3be3cfd38389ce2d8d9f38e990f8f32",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741420800,
      "headline": "I'm Locking 9-11% FCF Yields On These Dividend Icons",
      "id": 133106406,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1814819157/image_1814819157.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol Myers Squibb and Alexandria Real Estate are top picks for the income-focused, offering high dividends and growth potential. Click for more on BMY and ARE.",
      "url": "https://finnhub.io/api/news?id=36c0c846c535e0e09a1de09ae463b5dce3be3cfd38389ce2d8d9f38e990f8f32"
    }
  }
]